Back
Insmed, Inc. Stock Predictions
Exxon and Chevron Have an Unlikely New Competitor
DISCLOSURE: EnergyX's Regulation A offering has been qualified by the SEC. Before investing, carefully review the offering circular, including the risk factors. The offering circular is available at
Sell
50
INSM
Insmed, Inc.
Last Price:
$175.93
Seasonality Move:
3.26%
7 Day Trial
ALL ACCESS PASS
$
7
The Next Gold Rush
DISCLOSURE: EnergyX's Regulation A offering has been qualified by the SEC. Before investing, carefully review the offering circular, including the risk factors. The offering circular is available atInsmed, Inc. Stock Forecast
-
Over the next 52 weeks, Insmed, Inc. has on average historically risen by 38.4% based on the past 25 years of stock performance.
-
Insmed, Inc. has risen higher in 12 of those 25 years over the subsequent 52-week period, corresponding to a historical accuracy of 48%
-
Is Insmed, Inc. Stock Undervalued?The current Insmed, Inc. [INSM] share price is $175.97. The Score for INSM is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
-
INSM is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
Will Insmed, Inc. Stock Go Up Next Year?
-
Over the next 52 weeks, Insmed, Inc. has on average historically risen by 38.4% based on the past 25 years of stock performance.
Insmed, Inc. Stock Rating
Sell
50
Insmed, Inc. (INSM)
is a Sell
Is Insmed, Inc. overpriced?
-
Insmed, Inc. has risen higher in 12 of those 25 years over the subsequent 52-week period, corresponding to a historical accuracy of 48%
Insmed, Inc. Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
insmed.com
52-Week Data
52-Week High:
212.75
52-Week Low:
60.40
Prediction Charts
Market Cap:
37.5B
Price in USD:
175.97
Volume:
5.4M
Beta:
1.55
Technical Analysis
SMA50:
190.03
SMA100:
169.37
SMA200:
128.09
52-Wk Change:
167.76%
Stock Predictions
-
Is Insmed, Inc. stock public?Yes, Insmed, Inc. is a publicly traded company.
-
What is the Insmed, Inc. stock quote today?The Insmed, Inc. stock price is 175.97 USD today.
-
How to buy Insmed, Inc. stock online?You can buy Insmed, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Dec-19 | 168.30 | 174.84 | 178.21 | 166.71 |
| Dec-22 | 177.58 | 175.76 | 179.33 | 174.00 |
| Dec-23 | 174.17 | 176.77 | 177.60 | 172.65 |
| Dec-24 | 175.50 | 177.42 | 178.10 | 175.00 |
| Dec-26 | 177.40 | 177.88 | 179.44 | 176.67 |
| Dec-29 | 177.61 | 176.34 | 178.52 | 175.37 |
| Dec-30 | 175.79 | 174.09 | 176.52 | 173.48 |
| Dec-31 | 174.18 | 174.04 | 175.25 | 173.24 |
| Jan-2 | 175.79 | 177.12 | 177.90 | 173.55 |
| Jan-5 | 176.12 | 175.20 | 176.12 | 167.39 |
| Jan-6 | 173.33 | 175.07 | 175.41 | 170.94 |
| Jan-7 | 175.07 | 176.00 | 178.75 | 173.34 |
| Jan-8 | 174.17 | 170.27 | 175.00 | 168.01 |
| Jan-9 | 185.02 | 175.97 | 186.19 | 169.00 |
Insmed, Inc. Earnings
Insmed, Inc. Earnings Report: Per Share Insmed, Inc. Earnings Q1 Q2 Q3 and Q4 last year and next year.
Insmed, Inc. Forecast Revenue Growth
Insmed, Inc. Stock Analysis: Historical quarterly revenues per share for Insmed, Inc. and historical quarterly revenue growth:
-
Analysts estimate an earnings increase this quarter of $0.50 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.64 per share, and an increase next year of $2.63 per share.
* Insmed, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.